Related Experiment Videos
Piperidineacrylate derivatives as potential antiallergy agents
M Sugiyama1, T Sakamoto, Y Kamigaki
1Medicinal Chemistry Research Laboratory, Sankyo Co., Ltd., Tokyo, Japan.
Chemical & Pharmaceutical Bulletin
|May 1, 1993
Summary
Researchers developed novel piperidineacrylate derivatives for antiallergic potential. Compound 1a demonstrated superior efficacy in the rat passive cutaneous anaphylaxis (PCA) assay compared to existing drugs, warranting further investigation.
Area of Science:
- Medicinal Chemistry
- Pharmacology
Background:
- Allergic diseases represent a significant global health burden.
- Development of novel antiallergic agents is crucial for improved patient outcomes.
Purpose of the Study:
- To synthesize and evaluate a new series of piperidineacrylate derivatives for antiallergic activity.
- To identify lead compounds with potent antiallergic effects.
Main Methods:
- Synthesis of piperidineacrylate derivatives.
- Evaluation of antiallergic activity using the rat passive cutaneous anaphylaxis (PCA) assay.
- Comparative analysis with established antiallergic drugs (oxatomide, terfenadine).
Main Results:
- Most synthesized compounds exhibited significant antiallergic activity in the PCA assay.
- Ethyl 1-[2-bis(4-fluorophenyl)methoxyethyl]-4-piperidineacrylate (1a) displayed superior potency compared to oxatomide and terfenadine.
- Compound 1a was selected for further pharmacological characterization.
Conclusions:
- Piperidineacrylate derivatives represent a promising class of compounds for antiallergic drug development.
- Compound 1a shows significant potential as a novel therapeutic agent for allergic conditions.